Thomas F. Gajewski

Thomas Gajewski is a leader in understanding the tumor microenvironment and innate immune mechanisms that regulate anti-tumor immunity. His research has revealed the STING pathway's role in spontaneous anti-tumor T cell responses and developed strategies to convert non-T cell-inflamed tumors to inflamed phenotypes. Gajewski's work informs rational combination immunotherapy approaches.

Thomas Gajewski是理解肿瘤微环境和调节抗肿瘤免疫的先天免疫机制的领导者。他的研究揭示了STING通路在自发性抗肿瘤T细胞反应中的作用，并开发了将非T细胞浸润肿瘤转化为浸润表型的策略。Gajewski的工作为合理的联合免疫治疗方法提供了信息。